Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 2
1957 1
1966 3
1967 2
1968 3
1969 1
1970 2
1971 1
1972 1
1973 2
1975 1
1976 2
1977 2
1978 1
1979 1
1980 2
1981 2
1985 1
1987 1
1988 1
1989 1
1995 3
1997 5
1998 12
1999 40
2000 56
2001 65
2002 83
2003 77
2004 104
2005 113
2006 161
2007 141
2008 171
2009 195
2010 178
2011 204
2012 242
2013 264
2014 280
2015 296
2016 304
2017 329
2018 333
2019 145
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

3,175 results
Results by year
Filters applied: . Clear all
Page 1
Acetyl-l-carnitine deficiency in patients with major depressive disorder.
Nasca C, Bigio B, Lee FS, Young SP, Kautz MM, Albright A, Beasley J, Millington DS, Mathé AA, Kocsis JH, Murrough JW, McEwen BS, Rasgon N. Nasca C, et al. Proc Natl Acad Sci U S A. 2018 Aug 21;115(34):8627-8632. doi: 10.1073/pnas.1801609115. Epub 2018 Jul 30. Proc Natl Acad Sci U S A. 2018. PMID: 30061399 Free PMC article. Clinical Trial.
Molecular neurobiology of major depressive disorder.
Kim YK. Kim YK. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 4;64:275-6. doi: 10.1016/j.pnpbp.2015.07.004. Epub 2015 Jul 11. Prog Neuropsychopharmacol Biol Psychiatry. 2016. PMID: 26169576 No abstract available.
Inflammatory cytokines in major depressive disorder: A case-control study.
Cassano P, Bui E, Rogers AH, Walton ZE, Ross R, Zeng M, Nadal-Vicens M, Mischoulon D, Baker AW, Keshaviah A, Worthington J, Hoge EA, Alpert J, Fava M, Wong KK, Simon NM. Cassano P, et al. Aust N Z J Psychiatry. 2017 Jan;51(1):23-31. doi: 10.1177/0004867416652736. Epub 2016 Sep 29. Aust N Z J Psychiatry. 2017. PMID: 27313138 Free PMC article.
The 5-HT1A receptor in Major Depressive Disorder.
Kaufman J, DeLorenzo C, Choudhury S, Parsey RV. Kaufman J, et al. Eur Neuropsychopharmacol. 2016 Mar;26(3):397-410. doi: 10.1016/j.euroneuro.2015.12.039. Epub 2016 Jan 11. Eur Neuropsychopharmacol. 2016. PMID: 26851834 Free PMC article. Review.
Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder.
Jaso BA, Niciu MJ, Iadarola ND, Lally N, Richards EM, Park M, Ballard ED, Nugent AC, Machado-Vieira R, Zarate CA. Jaso BA, et al. Curr Neuropharmacol. 2017;15(1):57-70. doi: 10.2174/1570159x14666160321123221. Curr Neuropharmacol. 2017. PMID: 26997505 Free PMC article. Review.
The Role of Chemokines in the Pathophysiology of Major Depressive Disorder.
Milenkovic VM, Stanton EH, Nothdurfter C, Rupprecht R, Wetzel CH. Milenkovic VM, et al. Int J Mol Sci. 2019 May 9;20(9):2283. doi: 10.3390/ijms20092283. Int J Mol Sci. 2019. PMID: 31075818 Free PMC article. Review.
Dopamine System Dysregulation in Major Depressive Disorders.
Belujon P, Grace AA. Belujon P, et al. Int J Neuropsychopharmacol. 2017 Dec 1;20(12):1036-1046. doi: 10.1093/ijnp/pyx056. Int J Neuropsychopharmacol. 2017. PMID: 29106542 Free PMC article. Review.
Plasma metabolome analysis of patients with major depressive disorder.
Kawamura N, Shinoda K, Sato H, Sasaki K, Suzuki M, Yamaki K, Fujimori T, Yamamoto H, Osei-Hyiaman D, Ohashi Y. Kawamura N, et al. Psychiatry Clin Neurosci. 2018 May;72(5):349-361. doi: 10.1111/pcn.12638. Epub 2018 Mar 3. Psychiatry Clin Neurosci. 2018. PMID: 29356314 Free article.
3,175 results
Jump to page
Feedback